Article PDF
References
Gray M . Evidence-based healthcare: the 21st-century agenda. MRC News 1998;79:34–7.
Lueck CJ, McIlwaine GG, Zeidler M . Creutzfeldt-Jakob disease and the eye. II. Ophthalmic and neuro-ophthalmic features. Eye 2000;14:291–301.
Cuille J, Chelle P-L . Pathologie animale: la maladie dite tremblante du mouton est-elle inoculable? C R Acad Sci 1936;203:1552–4.
Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D . Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692–3.
Brown P . A therapeutic panorama of the spongiform encephalopathies. Antiviral Chern Chemother 1990;1:75–83.
Masters CL, Richardson EP . Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 1978;101:333–44.
Bell JE, Ironside JW . Neuropathology of spongiform encephalopathies in humans. Br Med Bull 1993;49:738–77.
Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995;5:459–66.
Landis DMD, Williams RS, Masters CL . Golgi and electronmicroscopic studies of spongiform encephalopathy. Neurology 1981;31:538–49.
McKinley MP, Bolton DC, Prusiner SB . A protease-resistant protein is a structural component of the scrapie prion. Cell 1983;35:57–62.
Brown P, Goldfarb LG, Gajdusek DC . The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist. Lancet 1991;337:1019–22.
Bendheim PE, Brown HR, Rudelli RD, et al. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 1992;42:149–56.
Pan K-M, Baldwin M, Nguyen J, et al. Conversion of IT-helices into f3-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993;90:10962–6.
Stahl N, Borchelt DR, Hsaio K, Prusiner SB . Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987;51:229–40.
DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beckstead JH, Prusiner SB . Changes in the localization of brain prion proteins during scrapie infection. Neurology 1987;37:1271–80.
Borchelt DR, Koliatsos VE, Guarnieri M, Pardo CA, Sisodia SS, Price DL . Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems. J Biol Chern 1994;269:14711–4.
Askanas V, Bilak M, Engel WK, Leclerc A, Tome F . Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions. Neurosci Lett 1993;159:111–4.
Kristensson K, Feurerstein B, Taraboulos A, Hyun WC, Prusiner SB, DeArmond SJ . Scrapie prions alter receptor-mediated calcium responses in cultured cells. Neurology 1993;43:2335–41.
Collinge J, Whittingon MA, Sidle KCL, et al. Prion protein is necessary for normal synaptic function. Nature 1994;370:295–7.
Whittingon MA, Sidle KC, Gowland I, et al. Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nature Genet 1995;9:197–201.
Brown DR, Besinger A . Prion protein expression and superoxide dismutase activity. Biochem J 1998;334:423–9.
Prusiner SB . Genetic and infectious prion diseases. Arch Neurol 1993;50:1129–53.
Gibbs CJ, Gajdusek DC, Asher DM, et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 1968;161:388–9.
Chapman J, Brown P, Rabey JM, et al. Transmission of spongiform encephalopathy from a familial Creutzfeldt-Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutation. Neurology 1992;42:1249–50.
Goldfarb LG, Brown P, Vrbovska A, et al. An insert mutation in the chromosome 20 amyloid precursor gene in a Gerstmann-Straussler-Scheinker family. J Neurol Sci 1992;111:189–94.
Masters CL, Gajdusek DC, Gibbs CJ . Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 1981;104:559–88.
Kimberlin RH, Hunter GD . DNA-synthesis in scrapie-affected mouse brain. J Gen Virol 1967;1:115–24.
Hope J . The nature of the scrapie agent: the evolution of the virino. Ann NY Acad Sci 1994;724:289.
Bolton DC, McKinley MP, Prusiner SB . Identification of a protein that purifies with the scrapie prion. Science 1982;218:1309–11.
Prusiner SB . Novel proteinaceous infectious particles cause scrapie. Science 1982;216:136–44.
Prusiner SB . Molecular biology of prion diseases. Science 1991;252:1515–21.
DeArmond SJ, Prusiner SB . Etiology and pathogenesis of prion diseases. Am J Pathol 1995;146:785–811.
Prusiner SB . Scrapie prions. Annu Rev Microbiol 1989;43:345–74.
Prusiner SB, Scott M, Foster D, et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 1990;63:673–86.
Weissmann C . The prion's progress. Nature 1991;349:569–71.
Prusiner SB . Prions. Proc Natl Acad Sci USA 1998;95:13363–83.
Forloni G, Angeretti N, Chiesa R, et al. Neurotoxicity of prion protein fragment. Nature 1993;362:543–6.
Forloni G, Angeretti N, Malesani P, et al. Influence of mutations associated with familial prion-related encephalopathies on biological activity of prion protein peptides. Ann Neurol 1999;45:489–94.
Prusiner SB, Groth D, Serban A, et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 1993;90:10608–12.
Gajdusek DC . Nucleation of amyloidogenesis in infectious and noninfectious amyloidoses of the brain. Ann NY Acad Sci 1994;724:173–90.
Prusiner SB . Prions and neurodegenerative diseases. N Engl J Med 1987;317:1571–81.
Goldfarb LG, Brown P . The transmissible spongiform encephalopathies. Annu Rev Med 1995;46:57–65.
Haywood AM . Transmissible spongiform encephalopathies. N Engl J Med 1997;337:1821–8.
Prusiner SB . Prion diseases and the BSE crisis. Science 1997;278:245–51.
Johnston RT, Gibbs CJ . Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339:1994–2004.
Creutzfeldt HG . Ùber eine eigenartige herdformige Erkrankung des Zentralnervensystems. Z Ges Neurol Psych 1920;57:1–18.
Jakob A . Ùber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischen Befunde (spastische Pseudosklerose -Encephalomyelopathie mit disseminierten Degenerationsherden). Z Ges Neurol Psych 1921;64:147–288.
Jakob A . Ùber eine der multiplen Sklerose klinisch nahestehende Erkrankung des Zentralnervensystems (spastische Pseudoskerlose) mit bemerkenswertem anatomischem Befunde. Mitteilung eines vierten Falles. Med Klin 1921;17:372–6.
Jakob A . Die extrapyramidalen Erkrankungen, mit besonderer Beriicksichtigung der pathologischen Anatomie und Histologie und der Pathophysiologie der Bewegungsstorungen. Monogr Psychiat (Berlin) 1923;37:215–45.
Spielmeyer W . Die histopathologische Forschung in der Psychiatrie. Klin Wochenschr 1922;1:1817–9.
Fischer O . Der spongiose Rindenschwund; ein besondere Destruktionsprozess der Hirnrinde. Z Ges Neurol Psych 1911;7:1–33.
Richardson EP, Masters CL . The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system. Brain Pathol 1995;5:33–41.
May WW . Creutzfeldt-Jakob disease. 1. Survey of the literature and clinical diagnosis. Acta Neurol Scand 1968;44:1–32.
Kirschbaum WR . Jakob-Creutzfeldt disease. New York: American Elsevier, 1968.
Gibbs CJ, Masters CL, Gajdusek DC . Bibliography of Creutzfeldt-Jakob disease. Bethesda: US Department of Health, Education and Welfare, Public Health Service, National Institutes of Health, 1979:149–52.
Masters CL, Harris JO, Gajdusek DC, Gibbs CJ, Bernoulli C, Asher DM . Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177–88.
Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J . Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996;53:913–20.
Matthews, WB . Epidemiology of Creutzfeldt-Jakob disease in England and Wales. J Neurol Neurosurg Psychiatry 1975;38:210–3.
Brown P, Cathala F . Creutzfeldt-Jakob disease in France: 1. Retrospective study of the Paris area during the ten-year period 1968-1977. Ann Neurol 1979;5:189–92.
Brown P, Cathala F, Sadowsky D, Gajdusek DC . Creutzfeldt-Jakob disease in France. II. Clinical characteristics of 124 consecutive verified cases during the decade 1968-1977. Ann Neurol 1979;6:430–7.
Brown P, Cathala F, Gajdusek DC . Creutzfeldt-Jakob disease in France. III. Epidemiological study of 170 patients dying during the decade 1968-1977. Ann Neurol 1979;6:438–46.
Cathala F, Brown P, Castaigne P, Gajdusek DC . La maladie de Creutzfeldt-Jakob en France continentale. Etude retrospective de 1968 a 1977. Rev Neurol (Paris) 1979;135:439–54.
Will RG . Epidemiology of Creutzfeldt-Jakob disease. Br Med Bull 1993;49:960–70.
Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P . The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987;37:895–904.
Masullo C, Pocchiari M, Neri G, et al. A retrospective study of Creutzfeldt-Jakob disease in Italy (1972-1986). Eur J Epidemiol 1988;4:482–7.
Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB . Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988;51:1113–9.
Desgrandchamps D, Rieder HL, Marti B . Incidence of Creutzfeldt-Jakob disease. Lancet 1994;343:1229.
Delasnerie-Laupretre N, Poser S, Pocchiari M, Wientjens DPWM, Will R . Creutzfeldt-Jakob disease in Europe. Lancet 1995;346:898.
Hofman A, Wientjens DPWM . Epidemiological evidence concerning a possible causal link. BMJ 1995;311:1418–9.
Hainfellner JA, Jellinger K, Diringer H, et al. Creutzfeldt-Jakob disease in Austria. J Neurol Neurosurg Psychiatry 1996;61:139–42.
Lundberg PO . Creutzfeldt-Jakob disease in Sweden. J Neurol Neurosurg Psychiatry 1998;65:836–41.
Davanipour Z, Smoak C, Bohr T, Sobel E, Liwnicz B . Rate of Creutzfeldt-Jakob disease in USA. Neurology 1993;43:A316.
Brown P, Gibbs CJ, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513–29.
Holman RC, Khan AS, Kent J, Strine TW, Schonberger LB . Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology 1995;14:174–81.
Kahana E, Alter M, Braham J, Sofer D . Creutzfeldt-Jakob disease: focus among Libyan Jews in Israel. Science 1974;183:90–1.
Galvez S, Masters C, Gajdusek DC . Descriptive epidemiology of Creutzfeldt-Jakob disease in Chile. Arch Neurol 1980;37:11–4.
Tsuji S, Kuroiwa Y . Creutzfeldt-Jakob disease in Japan. Neurology 1983;33:1503–6.
Nakamura Y, Yanagawa H, Hoshi K, Yoshino H, Urata J, Sato T . Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol 1999;28:130–4.
Neugut RH, Neugut AI, Kahana E, Stein Z, Alter M . Creutzfeldt-Jakob disease: familial clustering among Libyan-born Israelis. Neurology 1979;29:225–31.
Zilber N, Kahana E, Abraham M . The Libyan Creutzfeldt-Jakob disease focus in Israel: an epidemiologic evaluation. Neurology 1991;41:1385–9.
Gabizon R, Rosenman H, Meiner Z, et al. Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease. Phil Trans R Soc Lond B 1994;343:385–90.
Will RG . The epidemiology of Creutzfeldt-Jakob disease [thesis]. 1984. University of Cambridge.
Wientjens DPWM . Epidemiology of Creutzfeldt-Jakob disease: incidence, risk factors and survival in European studies [thesis]. 1997. University of Rotterdam.
Berman PH, Davidson GS, Becker LE . Progressive neurological deterioration in a 14-year-old girl. Paediatr Neurosci 1988;14:42–9.
Brown P, Cathala F, Castaigne P, Gajdusek DC . Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986;20:597–602.
World Health Organization. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. WHO/ EMC/ZDI/989 Geneva: World Health Organization, 1998.
Roos R, Gajdusek DC, Gibb CJ . The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain 1973;96:1–20.
De Silva R . Human spongiform encephalopathy. In: Baker HF, Ridley RM, editors. Methods in molecular medicine: prion diseases. Totowa, NJ: Humana Press, 1996:15–33.
Heidenhain A . Klinische und anatomische Untersuchungen uber eine eigenartige organische Erkrankung des Zentralnervensystems in Praesenium. Z Ges Neurol Psych 1928;118:49–114.
Meyer A, Leigh D, Bagg CE . A rare presenile dementia associated with cortical blindness (Heidenhain's syndrome). J Neurol Neurosurg Psychiatry 1954;17:129–33.
Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol 1999;56:55–61.
Motomura S, Yamashita Y, Kawanami S, Ohta M, Kuroiwa Y . An autopsy report of spongiform encephalopathy with Kuru plaque and leukomalacia. Rinsho Shinkeigaku - Clin Neurol 1977;17:758–64.
Park TS, Kleinman GM, Richardson EP . Creutzfeldt-Jakob disease with extensive degeneration of white matter. Acta Neuropathol (Berlin) 1980;52:239–42.
Mizutani T, Okumura A, Oda M, Shiraki H . Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J Neurol Neurosurg Psychiatry 1981;44:103–15.
Kitagawa Y, Gotoh F, Koto A, et al. Creutzfeldt-Jakob disease: a case with extensive white matter degeneration and optic atrophy. J Neurol 1983;229:97–101.
Macchi G, Abbamondi AL, Di Trapani G, Sbriccoli A . On the white matter lesions of the Creutzfeldt-Jakob disease. Can a new subentity be recognized in man? J Neurol Sci 1984;63:197–206.
Cruz-Sanchez F, Lafuente J, Gertz HJ, Stoltenburg-Didinger G . Spongiform encephalopathy with extensive involvement of white matter. J Neurol Sci 1987;82:81–7.
Okiyama R, Tsuchiya K, Furukawa T, Tsukagoshi H, Kosaka K . An autopsy case of panencephalopathic type of Creutzfeldt-Jakob disease: an early clinical sign documented by magnetic resonance imaging. Rinsho Shinkeigaku - Clin Neurol 1989;29:1048–51.
Berciano J, Berciano MT, Polo JM, Figols J, Ciudad J, Lafarga M . Creutzfeldt-Jakob disease with severe involvement of cerebral white matter and cerebellum. Virchows Arch A Pathol Anat Histopathol 1990;417:533–8.
Kruger H, Meesmann C, Rohrbach E, Muller J, Mertens HG . Panencephalopathic type of Creutzfeldt-Jakob disease with primary extensive involvement of white matter. Eur Neurol 1990;30:115–9.
Uchino A, Yoshinaga M, Shiokawa O, Hata H, Ohno M . Serial MR imaging in Creutzfeldt-Jakob disease. Neuroradiology 1991;33:364–7.
Brownell B, Oppenheimer DR . An ataxic form of subacute presenile polioencephalopathy (Creutzfeldt-Jakob disease). J Neurol Neurosurg Psychiatry 1965;28:350–61.
Jellinger K, Heiss W-D, Deisenhammer E . The ataxic (cerebellar) form of Creutzfeldt-Jakob disease. J Neurol 1974;207:289–305.
Gomori AJ, Partnow MJ, Horoupian DS, Hirano A . The ataxic form of Creutzfeldt-Jakob disease. Arch Neurol 1973;29:318–23.
Jones HR, Hedley-White ET, Freidberg SR, Baker RA . Ataxic Creutzfeldt-Jakob disease: diagnostic techniques and neuropathologic observations in early disease. Neurology 1985;35:254–7.
Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921–5.
Chazot G, Broussolle E, Lapras CI, Blattler T, Aguzzi A, Kopp N . New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 1996;347:1181.
Will RG, Matthews WB . A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. 1 Clinical features. J Neurol Neurosurg Psychiatry 1984;47:134–40.
Maertens P, Quindlen EA . Clinical manifestations. In: Bastian FO, editor. Creutzfeldt-Jakob disease and other transmissible spongiform encephalopathies. St Louis: Mosby-Year Book, 1991:131–52.
McNaughton HK, Will RG . Creutzfeldt-Jakob disease presenting acutely as stroke: an analysis of 30 cases. Neurol Infect Epidemiol 1996;2:19–24.
Hudson AJ . Amyotrophic lateral sclerosis and its association with dementia, Parkinsonism and other neurological disorders: a review. Brain 1981;104:217–47.
Antoine JC, Laplanche JL, Mosnier JF, Beaudry P, Chatelain J, Michel D . Demyelinating peripheral neuropathy with Creutzfeldt-Jakob disease and mutation at codon 200 of the prion protein gene. Neurology 1996;46:1123–7.
Esiri MM, Gordon WI, Collinge J, Patten JS . Peripheral neuropathy in Creutzfeldt-Jakob disease. Neurology 1997;48:784.
Collinge J, Owen F, Poulter M, et al. Prion dementia without characteristic pathology. Lancet 1990;336:7–9.
Packer RJ, Cornblath DR, Gonatas NK, Bruno LA, Asbury AK . Creutzfeldt-Jakob disease in a 20-year-old woman. Neurology 1980;30:492–6.
Monreal J, Collins GH, Masters CL, et al. Creutzfeldt-Jakob disease in an adolescent. J Neurol Sci 1981;52:341–50.
Galvez S, Dorr-Zegers O, Cartier L . Zur Klinik, Neuropathologie und Pathogenese der Creutzfeldt-Jakobschen Krankheit anhand von 40 gesicherten Fallen. Nervenarzt 1982;53:132–40.
Raverdy P, Hauw JJ, Cathala F, et al. Maladie de Creutzfeldt-Jakob ayant évolué 34 mois chez une femme de 26 ans. Rev Neurol (Paris) 1983;139:381–3.
Brown P, Cathala F, Labauge R, Pages M, Alary JC, Baron H . Epidemiologic implications of Creutzfeldt-Jakob disease in a 19-year-old girl. Eur J Epidemiol 1985;1:42–7.
Kulczycki J, Jedrzejowska H, Gajkowski K, Tarnowska-Dziduszko E, Lojkowska W . Creutzfeldt-Jakob disease in young people. Eur J Epidemiol 1991;7:501–4.
Bateman D, Hilton D, Love S, Zeidler M, Beck J, Collinge J . Sporadic Creutzfeldt-Jakob disease in an 18-year-old in the UK. Lancet 1995;346:1155–6.
Britton TC, Al-Sarraj S, Shaw C, Campbell T, Collinge J . Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet 1995;346:1155.
Ironside JW, Sutherland K, Bell JE, et al. A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. Cold Spring Harbor Symp Quant Biol 1996;61:523–30.
Will RG, Stewart G, Zeidler M, MacLeod MA, Knight RSG . Psychiatric features of new variant Creutzfeldt-Jakob disease. Psychol Bull 1999;23:264–7.
Zeidler M, Stewart GE, Barraclough CR, et al. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 1997;350:903–7.
Zeidler M, Johnstone EC, Bamber RWK, et al. New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 1997;350:908–10.
Sellar RJ, Will W, Zeidler M . Imaging of new variant Creutzfeldt disease: the pulvinar sign. Neuroradiology 1997;39(Suppl):S53.
Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000;355:1412–8.
Wells GAH, Scott AC, Johnson CT, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987;121:419–20.
Alperovitch A, Brown P, Weber T, Pocchiari M, Hofman A, Will R . Incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet 1994;343:918.
Wilesmith JW, Ryan JBM, Atkinson MJ . Bovine spongiform encephalopathy: epidemiological studies on the origin. Vet Rec 1991;128:199–203.
Anderson RM, Donnelly CA, Ferguson NM, et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996;382:779–88.
Sawcer SJ, Yuill GM, Esmonde TFG, et al. Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE. Lancet 1993;341:642.
Davies PTG, Jahfar S, Ferguson IT, Windl O . Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE. Lancet 1993;342:680.
Smith PEM, Zeidler M, Ironside JW, Estibeiro P, Moss TH . Creutzfeldt-Jakob disease in a dairy farmer. Lancet 1995;346:898.
Young GR, Fletcher NA, Zeidler M, Estibeiro KL, Ironside JW . Creutzfeldt-Jakob disease in a beef farmer. Lancet 1996;348:610–1.
Gore SM . More than happenstance: Creutzfeldt-Jakob disease in farmers and young adults. BMJ 1995;511:1416–8.
Hill F, Will PG, Ironside J, Collinge J . Type of prion protein in UK farmers with Creutzfeldt-Jakob disease. Lancet 1997;350:188.
Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 1997;389:498–501.
Ironside JW, Knight RSG, Will RG, Smith PG, Cousens SN . New variant Creutzfeldt-Jakob disease is more common in Britain than elsewhere. BMJ 1998;317:352.
Lasmézas CI, Deslys J-P, Demaimay R, Adjou KT, Lamoury F, Dormont D . BSE transmission to macaques. Nature 1996;381:743–4.
Hill AF, Debruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997;389:448–50.
Almond J, Pattison J . Human BSE. Nature 1997;389:437–8.
Bruce ME, Will RG, Ironside JW, Fraser H . Comparison of the biological characteristics of BSE and CJD in mice. In: Iqbal K, Swaab DF, Winblad B, Wisniewski H, editors. Alzheimer's disease and related disorders. London: Wiley, 1999:553–60.
Zeidler M, Stewart G, Cousens SN, Estibeiro K, Will RG . Codon 129 genotype and new variant CJD. Lancet 1997;350:668.
Cousens SN, Linsell L, Smith PG, et al. Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet 1999;353:18–21.
Cousens SN, Vynnycky E, Zeidler M, Will RG, Smith PG . Predicting the CJD epidemic in humans. Nature 1997;385:197–8.
Dealler SF . Predictions of the incidence of new variant Creutzfeldt-Jakob disease. Rev Med Microbiol 1998;9:129–34.
Ghani AC, Ferguson NM, Donnelly CA, Hagenaars TJ, Anderson RM . Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. Proc R Soc Lond B 1998;265:2443–52.
Thomas P, Newby M . Estimating the size of the outbreak of new-variant CJD. Br Food J 1999;101:44–58.
Will RG, Cousens SN, Farrington CP, Smith PG, Knight RSG, Ironside JW . Deaths from variant Creutzfeldt-Jakob disease. Lancet 1999;353:979.
Anon. Tragedy of variant Creutzfeldt-Jakob disease [editorial]. Lancet 1999;353:939.
Gerstmann J, Straussler E, Scheinker I . Uber eine eigenartige hereditar-familiare Erkrankung des Zentralnervensystems. Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z Ges Neurol Psych 1936;154:736–62.
Hsaio K, Prusiner SB . Inherited human prion diseases. Neurology 1990;40:1820–7.
Hainfellner JA, Brantner-Inthaler S, Cervenâkovâ L, et al. The original Gerstmann-Straussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 1995;5:201–11.
Doh-ura K, Tateishi J, Kitamoto T, Sasaki H, Sakaki Y . Creutzfeldt-Jakob disease patients with congophilic kuru plaques have the missense variant prion protein common to Gerstmann-Straussler syndrome. Ann Neurol 1990;27:121–6.
Warter JM, Steinmetz G, Heldt N, et al. Démence pré-sénile familiale: syndrome de Gerstmann-Straussler-Scheinker. Rev Neurol (Paris) 1982;138:107–21.
Nochlin D, Sumi SM, Bird TD, et al. Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Straussler syndrome. Neurology 1989;39:910–8.
Hsaio KK, Cass C, Schellenberg GD, et al. A prion protein variant in a family with the telencephalic form of Gerstmann-Straussler-Scheinker syndrome. Neurology 1991;41:681–4.
Farlow MR, Yee RD, Dlouhy SR, Conneally PM, Azzarelli B, Ghetti B . Gerstmann-Straussler-Scheinker disease. I. Extending the clinical spectrum. Neurology 1989;39:1446–52.
Ghetti B, Tagliavini F, Masters CL, et al. Gerstmann-Straussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 1989;39:1453–61.
Lugaresi E, Medori R, Montagna P, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986;315:997–1003.
Medori R, Tritschler HJ, LeBlanc A, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992;326:444–9.
Manetto V, Medori R, Cortelli P, et al. Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 1992;42:312–9.
Petersen RB, Tabaton M, Berg L, et al. Analysis of the prion protein gene in thalamic dementia. Neurology 1992;42:1859–63.
Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992;258:806–8.
Gambetti P, Petersen R, Monari L, et al. Fatal familial insomnia and the widening spectrum of prion diseases. Br Med Bull 1993;49:980–94.
Nagayama M, Shinohara Y, Furukawa H, Kitamoto T . Fatal familial insomnia with a mutation at codon 178 of the prion protein gene: first report from Japan. Neurology 1996;47:1313–6.
Gambetti P, Parchi P . Insomnia in prion diseases: sporadic and familial. N Engl J Med 1999;340:1675–7.
Campbell TA, Palmer MS, Will RG, Gibb WRG, Luthert PJ, Collinge J . A prion disease with a novel 96-base pair insertional mutation in the prion protein gene. Neurology 1996;46:761–6.
Mastrianni JA, Nixon R, Layzer R, et al. Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 1999;340:1630–8.
Zerr I, Giese A, Windl O, et al. Phenotypic variability in fatal familial insomnia (D178N-129M) genotype. Neurology 1998;51:1398–405.
Gajdusek DC, Zigas V . Degenerative disease of the central nervous system in New Guinea: the endemic occurrence of ‘kuru’ in the native population. N Engl J Med 1957;257:974–8.
Glasse R . Cannibalism in the Kuru region of New Guinea. Trans NY Acad Sci 1967;29:748–54.
Gajdusek DC . Unconventional viruses and the origin and disappearance of Kuru. Science 1977;197:943–60.
Liberski PP, Gajdusek DC Kuru: forty years later. A historical note. Brain Pathol 1997;7:555–60.
Will RG . Surveillance of prion diseases in humans. In: Baker HF, Ridley RM, editors. Methods in molecular medicine: prion diseases. Totowa, NJ: Humana Press, 1996:119–37.
Hsaio K, Meiner Z, Kahana E, et al. Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med 1991;324:1091–7.
Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD . The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 1994;44:1683–6.
Spudich S, Mastrianni JA, Wrensch M, et al. Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med 1995;1:607–13.
Sparkes RS, Simon M, Cohn VH, et al. Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci USA 1986;83:7358–62.
Owen F, Poulter M, Lofthouse R, et al. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1989;1:51–2.
Goldfarb LG, Brown P, Little BW, et al. A new (two repeat) octapeptide coding insert mutation in Creutzfeldt-Jakob disease. Neurology 1993;43:2392–4.
Goldfarb LG, Brown P, McCombie WR, et al. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 1991;88:10926–30.
Owen F, Poutler M, Shah T, et al. An in-frame insertion in the prion protein gene in familial Creutzfeldt-Jakob disease. Brain Res Mol Brain Res 1990;7:273–6.
Poulter M, Baker HF, Frith CD, et al. Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain 1992;115:675–85.
Collinge J, Brown J, Hardy J, et al. Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 1992;115:687–710.
Nicholl D, Windl O, De Silva R, et al. Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. J Neurol Neurosurg Psychiatry 1995;58:65–9.
Oda T, Kitamoto T, Tateishi J, et al. Prion disease with 144 base pair insertion in a Japanese family line. Acta Neuropathol 1995;90:80–6.
Cochran EJ, Bennett DA, Cervenakova L et al. Familial Creutzfeldt-Jakob disease with a five-repeat octapeptide insert mutation. Neurology 1996;47:727–33.
Brown P, Goldfarb LG, McCombie WR, et al. Atypical Creutzfeldt-Jakob disease in an American family with an insert mutation in the PRNP amyloid precursor gene. Neurology 1992;42:422–7.
Van Gool WA, Hansels GW, Hoogerwaard EM, Wiezer JHA, Wesseling P, Bolhuis PA . Hypokinesia and presenile dementia in a Dutch family with a novel insertion in the prion protein gene. Brain 1995;118:1565–71.
Owen F, Poulter M, Collinge J, et af . A dementing illness associated with a novel insertion in the prion protein gene. Brain Res Mol Brain Res 1992;13:155–7.
Duchen LW, Poulter M, Harding AE . Dementia associated with a 216 base pair insertion in the prion protein gene: clinical and neuropathological features. Brain 1993;116:555–67.
Brown P . The phenotypic expression of different mutations in transmissible human spongiform encephalopathy. Rev Neurol (Paris) 1992;148:317–27.
Goldfarb LG, Brown P, Cervenakova L, Gajdusek DC Molecular genetic studies of Creutzfeldt-Jakob disease. Mol Neurobiol 1994;8:89–97.
Doh-ura K, Tateishi J, Sasaki H, Kitamoto T, Sakaki Y . Pro-> Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Straussler syndrome. Biochem Biophys Res Commun 1989;163:974–9.
Hsaio K, Baker HF, Crow TJ, et al. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 1989;338:342–5.
Goldgaber D, Goldfarb LG, Brown P, et al. Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker's syndrome. Exp Neurol 1989;106:204–6.
Kretzschmar HA, Honold G, Seitelberger F, et al. Prion protein mutation in family first reported by Gerstmann, Straussler, and Scheinker. Lancet 1991;337:1160.
Kretzschmar HA, Kufer P, Riethmiiller G, DeArmond S, Prusiner SB, Schiffer D . Prion protein mutation at codon 102 in an Italian family with Gerstmann-Straussler-Scheinker syndrome. Neurology 1992;42:809–10.
Miyazono M, Kitamoto T, Doh-ura K, Iwaki T, Tateishi J . Creutzfeldt-Jakob disease with codon 129 polymorphism (valine): a comparative study of patients with codon 102 point mutation or without mutations. Acta Neuropathol 1992;84:349–54.
Goldhammer Y, Gabizon R, Meiner Z, Sadeh M . An Israeli family with Gerstmann-Straussler-Scheinker disease manifesting the codon 102 mutation in the prion protein gene. Neurology 1993;43:2718–9.
Laplanche J-L, Delasnerie-Lauprêtre N, Brandel JP, et al. Molecular genetics of prion diseases in France. Neurology 1994;44:2347–51.
Furukawa H, Kitamoto T, Tanaka Y, Tateishi J . New variant prion protein in a Japanese family with Gerstmann-Straussler syndrome. Brain Res Mol Brain Res 1995;30:385–8.
Young K, Jones CK, Piccardo P, et al. Gerstmann-Straussler-Scheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients. Neurology 1995;45:1127–34.
Barbanti P, Fabbrini G, Salvatore M, et al. Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation). Neurology 1996;47:734–41.
Piccardo P, Dlouhy S, Lievens PMJ, et al. Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 1998;57:979–88.
Kitamoto T, Amano N, Terao Y, et al. A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann Neurol 1993;34:808–13.
Kitamoto T, Ohta M, Doh-ura K, Hitoshi S, Terao Y, Tateishi J . Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome. Biochem Biophys Res Commun 1993;191:709–14.
Yamada M, Itoh Y, Fujigasaki H, et al. A missense mutation at codon 105 with codon 129 polymorphism of the prion protein gene in a new variant of Gerstmann-Straussler-Scheinker disease. Neurology 1993;43:2723–4.
Tateishi J, Kitamoto T, Doh-ura K, et al. Immunochemical, molecular genetic, and transmission studies on a case of Gerstmann-Straussler-Scheinker syndrome. Neurology 1990;40:1578–81.
Tranchant C, Doh-ura K, Warter JM, et al. Gerstmann-Straussler-Scheinker disease in an Alsatian family: clinical and genetic studies. J Neurol Neurosurg Psychiatry 1992;55:185–7.
Kitamoto T, Iizuka R, Tateishi J . An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 1993;192:525–31.
Samaia HB, de Jesus Mari J, Vallada HP, Moura RP, Simpson AJG, Brentani RR . A prion-linked psychiatric disorder. Nature 1997;390:241.
Fink JK, Warren JT, Drury I, Murman D, Peacock ML . Allele-specific sequencing confirms novel prion gene polymorphism in Creutzfeldt-Jakob disease. Neurology 1991;41:1647–50.
Goldfarb LG, Haltia M, Brown P, et al. New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob disease kindred. Lancet 1991;337:425.
Nieto A, Goldfarb LG, Brown P, et al. Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet 1991;337:622–3.
Bosque PJ, Vnencak-Jones CL, Johnson MD, Whitlock JA, McLean MJ . A PrP gene codon 178 base substitution and a 24-bp interstitial deletion in familial Creutzfeldt-Jakob disease. Neurology 1992;42:1864–70.
Brown P, Goldfarb LG, Kovanen J, et al. Phenotypic characteristics of familial Creutzfeldt-Jakob disease associated with the codon 178Asn PRNP mutation. Ann Neurol 1992;31:282–5.
Goldfarb LG, Brown P, Haltia M, et al. Creutzfeldt-Jakob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin. Ann Neurol 1992;31:274–81.
Petersen RB, Goldfarb L, Tabaton M, et al. Fatal familial insomnia and one subtype of familial Creutzfeldt-Jakob disease: effect of a polymorphism in the prion protein gene on pathogenic mutation. Neurology 1993;43(Suppl):A192.
Hitoshi S, Nagura H, Yamanouchi H, Kitamoto T . Double mutations at codon 180 and codon 232 of the PKNP gene in an apparently sporadic case of Creutzfeldt-Jakob disease. J Neurol Sci 1993;120:208–12.
Nitrini R, Rosemberg S, Passos-Bueno MR, et al. Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 1997;42:138–46.
Dlouhy SR, Hsaio K, Farlow MR, et al. Linkage of the Indiana kindred of Gerstmann-Straussler-Scheinker disease to the prion protein gene. Nature Genet 1992;1:64–7.
Hsaio K, Dlouhy SR, Farlow MR, et al. Mutant prion proteins in Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles. Nature Genet 1992;1:68–71.
Goldfarb LG, Mitrova E, Brown P, Toh BH, Gajdusek DC . Mutation of codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet 1990;336:514–5.
Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC . Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 1990;336:637–8.
Goldfarb LG, Brown P, Goldgaber D, et al. Identical mutation in unrelated patients with Creutzfeldt-Jakob disease. Lancet 1990;336:174–5.
Korczyn AD, Chapman J, Goldfarb LG, Brown P, Gajdusek DC . A mutation in the prion protein gene in Creutzfeldt-Jakob disease in Jewish patients of Libyan, Greek and Tunisian origin. Ann NY Acad Sci 1991;640:171–6.
Bertoni JM, Brown P, Goldfarb LG, Rubenstein R, Gajdusek DC . Familial Creutzfeldt-Jakob disease (codon 200 mutation) with supranuclear palsy. JAMA 1992;268:2413–5.
Brown P, Galvez S, Goldfarb LG, et al. Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J Neurol Sci 1992;112:65–7.
Chapman J, Brown P, Goldfarb LG, Arlazoroff A, Gajdusek DC, Korczyn AD . Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 1993;56:1109–12.
Collinge J, Palmer MS, Campbell T, Sidle KCL, Carroll D, Harding A . Inherited prion disease (PrP lysine 200) in Britain: two case reports. BMJ 1993;306:301–2.
Ripoll L, Laplanche J-L, Salzmann M, et al. A new point mutation in the prion protein gene at codon 210 in Creutzfeldt-Jakob disease. Neurology 1993;43:1934–8.
Inoue I, Kitamoto T, Doh-ura K, Shii H, Goto I, Tateishi J . Japanese family with Creutzfeldt-Jakob disease with codon 200 point mutation of the prion protein gene. Neurology 1994;44:299–301.
Chapman J, Arlazoroff A, Goldfarb LG, et al. Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200Lys mutation. Neurology 1996;46:758–1.
Miyakawa T, Inoue K, Iseki E, et al. Japanese Creutzfeldt-Jakob disease patients exhibiting high incidence of the E200K PRNP mutation and located in the basin of a river. Neurol Res 1998;20:684–8.
Mastrianni JA, Iannicola C, Myers RM, DeArmond S, Prusiner SB . Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease. Neurology 1996;47:1305–12.
Pocchiari M, Salvatore M, Cutruzzola F, et al. A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. Ann Neurol 1993;34:802–7.
Shimizu T, Tanaka K, Tanahashi N, Fukuuchi Y, Kitamoto T . Creutzfeldt-Jakob disease with a point mutation at codon 232 of prion protein: a case report. Rinsho Shinkeigaku -Clin Neurol 1994;24:590–2.
Itoh Y, Amano T, Shimizu T, Hashimoto J, Kubo A, Fukuuchi Y . Single-photon emission computed tomography image of benzodiazepine receptors in a patient with Creutzfeldt-Jakob disease. Int Med 1998;37:896–900.
Rosenmann H, Halimi M, Kahana I, Biran I, Gabizon R. Differential allelic expression of PrP mRNA in carriers of the E200K mutation. Neurology 1997;49:851–6.
Vnencak-Jones CL, Phillips JA . Identification of heterogeneous PrP gene deletions in controls by detection of allele-specific heteroduplexes (DASH). Am J Hum Genet 1992;50:871–2.
Prusiner SB, Scott MR . Genetics of prions. Annu Rev Genet 1997;31:139–75.
Kimberlin RH . Transmissible encephalopathies in animals. Can J Vet Res 1990;54:30–7.
Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H . Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Phil Trans R Soc Lond B 1994;343:405–11.
Bruce ME . Scrapie strain variation and mutation. Br Med Bull 1993;49:822–38.
Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF . Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 1996;383:685–90.
Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767–78.
Deslys J-P, Lasmézas C, Dormont D . Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease. Lancet 1994;343:848–9.
Brown P, Preece MA, Will RG . ‘Friendly fire’ in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992;340:24–7.
Esmonde T, Lueck CJ, Symon L, Duchen LW, Will RG . Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases. J Neurol Neurosurg Psychiatry 1993;56:999–1000.
Kimberlin RH, Walker CA . Pathogenesis of experimental scrapie. CIBA Found Symp 1988;1135:37–62.
Kimberlin RH, Walker CA . Pathogenesis of scrapie in mice after intragastric infection. Virus Res 1989;12:213–20.
Hadlow WJ, Kennedy RC, Race RE . Natural infection of Suffolk sheep with scrapie virus. J Infect Dis 1982;146:657–64.
Alperovitch A, Zerr I, Pocchiari M, et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999;353:1673–4.
De Silva R, Ironside JW, McCardle L, et al. Neuropathological phenotype and ‘prion protein’ genotype correlation in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 1994;179:50–2.
Doh-ura K, Kitamoto T, Sakaki Y, Tateishi J . CJD discrepancy. Nature 1991;353:801–2.
Tranchant C, Geranton L, Guiraud-Chaumeil C, Mohr M, Warter JM . Basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Neurology 1999;52:1244–9.
Baker HF, Poulter M, Crow TJ, et al. Aminoacid polymorphism in human prion protein and age at death in inherited prion disease. Lancet 1991;337:1286.
Brown P, Cervenakova L, Goldfarb LG, et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modem medicine. Neurology 1994;44:291–3.
Heckmann JG, Lang CJG, Petruch F, et al. Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry 1997;63:388–90.
Lang CJG, Heckmann JG, Neundorfer B . Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci 1998;160:128–39.
Martfnez-Lage JF, Poza M, Sola J, et al. Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts. J Neurol Neurosurg Psychiatry 1994;57:1091–4.
Yamada S, Aiba T, Endo Y, Hara M, Kitamoto T, Tateishi J . Creutzfeldt-Jakob disease transmitted by a cadaveric dura mater graft. Neurosurgery 1994;34:740–4.
Yamada M, Itoh Y, Suematsu N, Matsushita M, Otomo E . Panencephalopathic type of Creutzfeldt-Jakob disease associated with cadaveric dura mater graft. J Neurol Neurosurg Psychiatry 1997;63:524–7.
Antoine JC, Michel D, Bertholon P, et al. Creutzfeldt-Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma. Neurology 1997;48:1451–3.
Pocchiari M, Masullo C, Salvatore M, Genuardi M, Galgani S . Creutzfeldt-Jakob disease after commercial dura mater graft. Lancet 1992;340:614–5.
Goldfarb LG, Brown P, Goldgaber D, et al. Patients with Creutzfeldt-Jakob disease and kuru lack the mutation in the PRIP gene found in Gerstmann-Straussler syndrome, but they show a different double-allele mutation in the same gene. Am J Hum Genet 1989;45(Suppl):A189.
Collinge J, Palmer MS, Dryden AJ . Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991;337:1441–2.
Labauge P, Pages M, Blard J-M, Chatelain J, Laplanche J-L . Valine homozygous 129 PrP genotype in a French growth-hormone-related Creutzfeldt-Jakob disease patient. Neurology 1993;43:447.
Billette de Villemeur T, Gelot T, Deslys JP, et al. Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study. Neuropathol Appl Neurobiol 1994;20:111–7.
Masson C, Delalande I, Deslys JP, et al. Creutzfeldt-Jakob disease after pituitary-derived human growth hormone therapy: two cases with valine 129 homozygous genotype. Neurology 1994;44:179–80.
Deslys JP, Jaegly A, d'Aignaux JH, Mouthon F, Billette de Villemeur T, Dormont D. Genotype at codon 129 and susceptibility to Creutzfeldt-Jakob disease. Lancet 1998;351:1251.
Dickinson AG . Scrapie in sheep and goats. Front Biol 1976;44:209–41.
Kimberlin RH, Cole S, Walker CA . Temporary and permanent modification to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Virol 1987;68:1875–81.
Kimberlin RH, Walker CA, Fraser H . The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. J Gen Virol 1989;70:2017–25.
Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995;83:79–90.
Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL . Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999;353:693–7.
Will RG, Kimberlin RH . Creutzfeldt-Jakob disease and the risk from blood or blood products. Vox Sang 1998;75:178–80.
Elliott V . CJD fear prompts rule on contact lens fitting. The London Times, 24 June 1999. London.
Gaytan-Garcia S, Gilbert JJ, Kaufmann JCE . Jakob-Creutzfeldt disease associated with Wernicke encephalopathy. Can J Neurol Sci 1988;15:156–60.
Smith SJM, Kocen RS . A Creutzfeldt-Jakob like syndrome due to lithium toxicity. J Neurol Neurosurg Psychiatry 1988;51:120–3.
Kemperman CJF, Notermans SLH . Creutzfeldt-Jakob like syndrome due to lithium toxicity. J Neurol Neurosurg Psychiatry 1989;52:291.
Pietrini W . Creutzfeldt-Jakob disease presenting as Wernicke-Korsakoff syndrome. J Neurol Sci 1992;108:149–53.
Seipelt M, Zerr I, Nau R, et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1999;66:172–6.
Ironside JW . Neuropathological diagnosis of human prion disease: morphological studies. In: Baker HF, Ridley RM, editors. Methods in molecular medicine: prion diseases. Totowa, NJ: Humana Press, 1996:35–57.
Hogan RN, Brown P, Heck E, Cavanagh HD . Risk of prion disease transmission from ocular donor tissue transplantation. Cornea 1999;18:2–11.
Blisard KS, Davis LE, Harrington MG, Lovell JK, Kornfield M, Berger ML . Pre-mortem diagnosis of Creutzfeldt-Jakob disease by detection of abnormal cerebrospinal fluid proteins. J Neurol Sci 1990;99:75–81.
Whittle IR, Will RG, Ironside JW . Brain biopsy and patients with atypical presentations of sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1997;63:547–8.
Castellani R, Parchi P, Stahl J, Capellari S, Cohen M, Gambetti P . Early pathologic and biochemical changes in Creutzfeldt-Jakob disease: study of brain biopsies. Neurology 1996;46:1690–3.
Poursines Y, Boudouresques J, Roger J . Processus dégénératif atrophique diffus, a prédominance thalamo-striée. Séméiologie extra-pyramidale et psychique variable. Évolution subaigue a terminaison démentielle. Rev Neurol (Paris) 1953;89:266–71.
Abbott J . The EEC in Jakob-Creutzfeldt's disease. EEG Clin Neurophysiol 1959;11:184–5.
Butler HM, Williams GH, McCormack LJ . Clinical observations on seven pathologically proved cases of Creutzfeldt-Jakob disease. Trans Am Neurol Assoc 1963;88:30–2.
Nelson JR, Leffman H . The human diffusely projecting system: evoked potentials and interactions. Arch Neurol 1963;8:544–56.
Small JG, Bleisch VR, Woolsey RM . Subacute spongiform encephalopathy: comment on the literature and case report. EEG Clin Neurophysiol 1964;17:451–72.
Lafon R, Labauge R, van Bogaert L, Castan P . Sur l'unité histopathologique des encéphalopathies subaigues (types Creutzfeldt-Jakob, Heidenhain et Nevin). Rev Neurol (Paris) 1965;112:201–27.
Nevin S . On some aspects of cerebral degeneration in later life. Proc R Soc Lond B 1967;60:517–26.
Gloor P, Kalabay O, Giard N . The electroencephalogram in diffuse encephalopathies: electroencephalographic correlates of grey and white matter lesions. Brain 1968;91:779–802.
Hauser-Dumur F, Radvanyi MF . Evolution électroencéphalographique de deux cas de syndrome de Creutzfeldt-Jakob tardifs. Rev Neurol (Paris) 1969;121:241–4.
Goldhammer Y, Bubis JJ, Sarova-Pinhas I, Braham J . Subacute spongiform encephalopathy and its relation to Jakob-Creutzfeldt disease: report on six cases. J Neurol Neurosurg Psychiatry 1972;35:1–10.
Lee RG, Blair RDG . Evolution of EEG and visual evoked response changes in Creutzfeldt-Jakob disease. EEG Clin Neurophysiol 1973;35:133–42.
Ott TH, Despland PA . Sur l'évolution électro-clinique d'une spongiose cérébrale. Schweiz Arch Neurol Neurochir Psychiatr 1975;116:93–106.
Goto K, Umezaki H, Suetsugu M . Electroencephalographic and clinicopathological studies on Creutzfeldt-Jakob syndrome. J Neurol Neurosurg Psychiatry 1976;39:931–40.
Szirmai I, Guseo A . Czopf J, Palffy G. Analysis of clinical and electrophysiological findings in Jakob-Creutzfeldt disease. Arch Psychol Nervenk 1976;222:315–23.
Paty J, Bonnaud E, Latinville D, et al. Corrélations électrophysiologiques, cliniques et anatomiques dans un cas de maladie de Creutzfeldt-Jakob (forme de Heidenhain). Rev Neurol (Paris) 1978;134:223–31.
Torres F, Hutton JT . Clinical neurophysiology of dementia. Neurol Clin 1986;4:369–86.
Court L, Bert J . Electrophysiologie des encéphalopathies transmissibles. Path Biol 1995;43:25–42.
Budka H, Aguzzi A, Brown P, et al. Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995;5:319–22.
Chiofalo N, Fuentes A, Galvez S . Serial EEG findings in 27 cases of Creutzfeldt-Jakob disease. Arch Neurol 1980;37:143–5.
Levy SR, Chiappa KH, Burke CJ, Young RR . Early evolution and incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease. J Clin Neurophysiol 1986;3:1–21.
Bortone E, Bettoni L, Giorgi C, Terzano MG, Trabattoni GR, Manda D . Reliability of EEG in the diagnosis of Creutzfeldt-Jakob disease. EEG Clin Neurophysiol 1994;90:323–30.
Steinhoff BJ, Racker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996;53:162–6.
Burger LJ, Rowan AJ, Goldensohn ES . Creutzfeldt-Jakob disease. An electroencephalographic study. Arch Neurol 1972;26:428–33.
Elliott F, Gardner-Thorpe C, Barwick DD, Foster JB . Jakob-Creutzfeldt disease: modification of clinical and electroencephalographic activity with methylphenidate and diazepam. J Neurol Neurosurg Psychiatry 1974;37:879–87.
Aguglia U, Farnarier G, Tinuper P, Rey M, Gomez M, Quattrone A . Subacute spongiform encephalopathy with periodic paroxysmal activities: clinical evolution and serial EEG findings in 20 cases. Clin Electroencephalogr 1987;18:147–58.
Kuritzky A, Davidovitch S, Sandbank U, Bechar M . Normal EEG in Creutzfeldt-Jakob disease. Neurology 1980;30:1134–5.
Zochodne DW, Young GB, McLachlan RS, Gilbert JJ, Vinters HV, Kaufmann JCE . Creutzfeldt-Jakob disease without periodic sharp wave complexes: a clinical, electroencephalographic, and pathologic study. Neurology 1988;38:1056–60.
Tietjen GE, Drury I . Familial Creutzfeldt-Jakob disease without periodic EEG activity. Ann Neurol 1990;28:585–8.
Donnet A, Farnarier G, Gambarelli D, Aguglia U, Regis H . Sleep electroencephalogram at the early stage of Creutzfeldt-Jakob disease. Clin Electroencephalogr 1992;23:118–25.
Aguglia U, Oliveri RL, Gambardella A, Zappia M, Quattrone A . Combined neurophysiological studies in Creutzfeldt-Jakob disease: a case report. Clin Electroencephalogr 1989;20:103–10.
Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi L . MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 1998;40:65–70.
Lee KE, Loh NK, Tan AK, Tija HT . Creutzfeldt-Jakob disease presenting with visual blurring, diplopia and visual loss: Heidenhain's variant. Ann Acad Med Singapore 1998;27:854–6.
Jibiki I, Fukushima T, Kobayashi K, Aoki T, Yamaguchi N . Antagonizing correlation between periodic synchronous discharges and photically induced giant evoked responses in Creutzfeldt-Jakob disease (Heidenhain type): a case study. Psych Clin Neurosci 1995;49:87–90.
Aoki T, Kobayashi K, Jibiki I, et al. An autopsied case of Creutzfeldt-Jakob disease with the lateral geniculate body lesion showing antagonizing correlation between periodic synchronous discharges and photically induced giant evoked responses. Psych Clin Neurosci 1998;52:333–7.
Capon A, Colin F, Deltenre P, Hubert JP, Flament-Durand J. Etude électrophysiologique de deux cas de maladie de Creutzfeldt-Jakob. Rev EEG Neurophysiol Clin 1976;6:130–6.
Adam J, Crow TJ, Duchen LW, Scaravilli F, Spokes E . Familial cerebral amyloidosis and spongiform encephalopathy. J Neurol Neurosurg Psychiatry 1982;45:37–45.
Wolpow ER, Richardson EP . Case records of the Massachusetts General Hospital. Case 45-1980. N Engl J Med 1980;303:1162–71.
Tintner R, Brown P, Hedley-White ET, Rappaport EB, Piccardo CP, Gajdusek DC . Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications. Neurology 1986;36:932–6.
Tsutsui J, Kawashima S, Kajikawa I, Shirabe T, Terao A. Electrophysiological and pathological studies on Creutzfeldt-Jakob disease with retinal involvement. Doc Ophthalmol 1986;63:13–21.
Aguglia U, Farnarier G, Regis H, Oliveri RL, Quattrone A . Sensory evoked potentials in Creutzfeldt-Jakob disease. Eur Neurol 1990;30:157–61.
Aguglia U, Gambarelli D, Farnarier G, Quattrone A . Different susceptibilities of the geniculate and extrageniculate visual pathways to human Creutzfeldt-Jakob disease (a combined neurophysiological-neuropathological study). EEG Clin Neurophysiol 1991;78:413–23.
Fukui R, Tobimatsu S, Kato M . Periodic synchronous discharges and visual evoked potentials in Creutzfeldt-Jakob disease: PSD-triggered flash VEPs. EEG Clin Neurophysiol 1994;90:433–7.
de Seze J, Hache JC, Vermersch P, et al. Creutzfeldt-Jakob disease: neurophysiologic visual impairments. Neurology 1998;51:962–7.
Neetens A, Martin JJ . Neuro-ophthalmological aspects of prion diseases. Neuro-ophthalmology 1998;19:137–44.
Aguglia U, Oliveri RL, Gambardella A, Quattrone A . Functional integrity of benzodiazepine receptors of the genicula-striate visual pathways in Creutzfeldt-Jakob disease. J Neurol 1993;240:25–7.
Powell-Jackson J, Weller RO, Kennedy P, Preece MA, Whitcombe EM, Newsom-Davis J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 1985;11:244–6.
Signorino M, Giovagnoli AR, Sirrocchi G, Censori B . Unusual findings in Creutzfeldt-Jakob disease: case report. Ital J Neurol Sci 1988;9:279–82.
Ehrenberg B, Munsat T, Sharetts S, Adelman L . Evoked potentials in Creutzfeldt-Jakob disease. Early diagnosis? EEG Clin Neurophysiol 1984;57:3P.
Richard P, Renault F, Ostré C, Auzoux-Chevé M. Neurophysiological follow-up in two children with Creutzfeldt-Jakob disease after human growth hormone treatment. EEG Clin Neurophysiol 1994;91:100–7.
Renault F, Richard P . Early electroretinogram alterations in Creutzfeldt-Jakob disease after growth hormone treatment. Lancet 1991;339:19l.
Billette de Villemeur T, Beauvais P, Gourmelen M, Richardet JM . Creutzfeldt-Jakob disease in children treated with growth hormone. Lancet 1991;337:864–5.
Billette de Villemeur T, Deslys J-P, Pradel A, et al. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology 1996;47:690–5.
Lesser RL, Albert DM, Bobowick AR, O'Brien FH . Creutzfeldt-Jakob disease and optic atrophy. Am J Ophthalmol 1979;87:317–2l.
Sato Y, Chiba S, Miyagishi T . A case of panencephalopathic type of Creutzfeldt-Jakob disease with retinal involvement. Hokkaido Igaku Zasshi - Hokkaido J Med Sci 1992;67:703–11.
Hogan RN, Kingsbury DT, Baringer JR, Prusiner SB . Retinal degeneration in experimental Creutzfeldt-Jakob disease. Lab Invest 1983;49:708–15.
Browne TR, Richardson EP . Case records of the Massachusetts General Hospital. Case 43-1977. N Engl J Med 1977;297:930–7.
Rao CVGK, Brennan TG, Garcia JH . Computed tomography in the diagnosis of Creutzfeldt-Jacob disease. J Comput Assist Tomogr 1977;1:211–5.
Rice GPA, Paty DW, Ball MJ, Tatham R, Kertesz A . Spongiform encephalopathy of long duration: a family study. Can J Neurol Sci 1980;7:171–6.
Zieger A, Vonofakos D, Grafin Vitzthum H. Creutzfeldt-Jakobsche Krankheit: Das Computertomogramm in Korrelation zu klinischen, elektroenzephalographischen und neuropathologischen Befunden. Nervenarzt 1981;52:685–91.
Khurana RK, Garcia JH . Autonomic dysfunction in subacute spongiform encephalpathy. Arch Neurol 1981;38:114–7.
Kashiwamura K, Takasato C, Kodama K, Kusunose Y, Sakata Y . Serial computed tomographic study on subacute spongiform encephalopathy. Clin Neurol 1981;21:938–43.
Schneck SA, Hedley-White ET . Case records of the Massachusetts General Hospital. Case 49-1983. N Engl J Med 1983;309:1440–9.
Friedland RP, Prusiner SB, Jagust WJ, Budinger TF, Davis RL . Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose. J Comput Assist Tomogr 1984;8:978–81.
Galvez S, Cartier L . Computed tomography findings in 15 cases of Creutzfeldt-Jakob disease with histological verification. J Neurol Neurosurg Psychiatry 1984;47:1244–71.
Westphal KP, Schachenmayr W . Computed tomography during Creutzfeldt-Jakob disease. Neuroradiology 1985;27:362–4.
Kovanen I, Erkinjuntti T, Iivanainen M, et al. Cerebral MR and CT imaging in Creutzfeldt-Jakob disease. J Comput Assist Tomogr 1985;9:125–8.
LeMay M . CT changes in dementing diseases: a review. Am J Neuroradiol 1986;7:841–53.
Chan YW, Ho HC, Kay CS, Ip YM . Creutzfeldt-Jakob disease in Hong Kong: a case report. J Neurol Sci 1987;80:143–52.
Kazukawa S, Nakamura I, Endo M, Hori A, Inao G . Serial polysomnograms in Creutzfeldt-Jakob disease. Jpn J Psychiatry Neurol 1987;41:651–61.
Gertz H-I, Henkes H, Cervos-Navarro J . Creutzfeldt-Jakob disease: correlation of MRl and neuropathologic findings. Neurology 1988;38:1481–2.
Schlenska GK, Walter GF . Serial computed tomographic findings in Creutzfeldt-Jakob disease. Neuroradiology 1989;31:303–6.
Pearl GS, Anderson RE . Creutzfeldt-Jakob disease: high caudate signal on magnetic resonance imaging. South Med J 1989;82:1177–80.
Cochius JI, Mack K, Burns RI, Alderman CP, Blumbergs PC . Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust NZ J Med 1990;20:592–3.
Holthoff VA, Sandmann I, Pawlik G, Schroder R, Heiss WD . Positron emission tomography in Creutzfeldt-Jakob disease. Arch Neurol 1990;47:1035–8.
Shishido F, Uemura K, Inugami A, et al. Brain glucose metabolism in a patient with Creutzfeldt-Jakob disease measured by positron emission tomography. Kaku Igaku - Japan J Nucl Med 1990;27:649–54.
Miyashita K, Inuzuka T, Kondo H, et al. Creutzfeldt-Jakob disease in a patient with a cadaveric dural graft. Neurology 1991;41:940–1.
Milton WJ, Atlas SW, Lavi E, Mollman JE . Magnetic resonance imaging of Creutzfeldt-Jakob disease. Ann Neurol 1991;29:438–40.
Falcone S, Quencer RM, Bowen B, Bruce JH, Naidich TP . Creutzfeldt-Jakob disease: focal symmetrical cortical involvement demonstrated by MR imaging. Am J Neuroradiol 1992;13:403–6.
Hayashi R, Hanyu N, Kuwabara T, Moriyama S . Serial computed tomographic and electroencephalographic studies in Creutzfeldt-Jakob disease. Acta Neurol Scand 1992;85:161–5.
Kohira I, Ishuzu H, Shohmori T, et al. Diffuse reduced uptake in 99mTc-HM-PAO SPECT and high level of neuron-specific enolase in cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease [in Japanese]. No to Shinkei - Brain Nerve 1992;44:579–82.
Sato Y, Chiba S, Miyagishi T, Hayasaka K . Serial brain CT and 123I-IMP SPECT in a case with Creutzfeldt-Jakob disease. Hokkaido Igaku Zasshi - Hokkaido J Med Sci 1992;67:141–7.
Barboriak DP, Provenzale JM, Boyko OB . MR diagnosis of Creutzfeldt-Jakob disease: significance of high signal intensity of the basal ganglia. AJR 1994;162:137–40.
Ogawa T, Inugami A, Fujita H, et al. Serial positron emission tomography with 18F-fluorodeoxyglucose in Creutzfeldt-Jakob disease. Am J Neuroradiol 1995;16:978–81.
Garcia Santos JM, Lopez Corbalan JA, Martinez-Lage JF, Sicilia Guillen J. CT and MRI in iatrogenic and sporadic Creutzfeldt-Jakob disease: as far as imaging perceives. Neuroradiology 1996;38:226–31.
Onofrj M, Fulgente T, Gambi D, Macchi G . Early MRl findings in Creutzfeldt-Jakob disease. J Neurol 1993;240:423–6.
Koch TK, Berg BO, De Armond SI, Gravina RF . Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism: possible relation to the administration of cadaveric human growth hormone. N Engl J Med 1985;313:731–3.
Berciano I, Diez C, Polo JM, Pascual J, Figols J . CT appearance of panencephalopathic and ataxic type of Creutzfeldt-Jakob disease. J Comput Assist Tomogr 1991;15:332–4.
Kawata A, Suga M, Oda M, Hayashi H, Tanabe H . Creutzfeldt-Jakob disease with congophilic Kuru plaques: CT and pathological findings of the cerebral white matter. J Neurol Neurosurg Psychiatry 1992;55:849–51.
Berciano I, Pascual I, Polo JM, Combarros O, Figols I, Diez C. Ataxic type of Creutzfeldt-Jakob disease with disproportionate enlargement of the fourth ventricle: a serial CT study. J Neurol Neurosurg Psychiatry 1997;62:295–7.
Esmonde TFG, Will RG . Magnetic resonance imaging in Creutzfeldt-Jakob disease. Ann Neurol 1992;31:230–1.
Rother I, Schwartz A, Harle M, Wentz KU, Berlit P, Hennerici M . Magnetic resonance imaging follow-up in Creutzfeldt-Jakob disease. J Neurol 1992;239:404–6.
Yamamoto K, Morimatsu M . Increased signal in basal ganglia and white matter on magnetic resonance imaging in Creutzfeldt-Jakob disease. Ann Neurol 1992;32:114.
Di Rocco A, Molinari S, Stollman AL, Decker A, Yahr MD . MRl abnormalities in Creutzfeldt-Jakob disease. Neuroradiology 1993;35:584–5.
Tartaro A, Fulgente T, Delli Pizzi C, Bonomo L, Bocola V, Onofrj M . MRl alterations as an early finding in Creutzfeld-Jakob disease. Eur J Radiol 1993;17:155–8.
Iwasaki Y, Ikeda K, Tagaya N, Kinoshita M . Magnetic resonance imaging and neuropathological findings in two patients with Creutzfeldt-Jakob disease. J Neurol Sci 1994;126:228–31.
Heinz A, Schmidt LG, Winterer G, Gerhard L, Przuntek H . Optische und taktile Halluzinose als klinischer Beginn einer Creutzfeldt-Jakob-Erkrankung. Nervenarzt 1995;66:712–6.
Kujat C, Hagen T, Feiden W . Creutzfeldt-Jakob-Krankheit. Welche Rolle spielt die MR-Tomographie? Radiologe 1995;35:834–7.
Finkenstaedt M, Szudra A, Zerr I, et al. MR imaging of Creutzfeldt-Jakob disease. Radiology 1996;199:793–8.
Gold M, Rojiani A, Murtaugh R . A 66-year-old woman with a rapidly progressing dementia and basal ganglia involvement. J Neuroimaging 1997;7:171–5.
Yoon SS, Chan S, Chin S, Lee K, Goodman RR . MRl of Creutzfeldt-Jakob disease: asymmetric high signal intensity of the basal ganglia. Neurology 1995;45:1932–3.
Hill AF, Butterworth RI, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183–9.
Falcone S, Quencer RM, Donovan Post MJ . Magnetic resonance imaging of unusual intracranial infections. Top Magn Reson Imaging 1994;6:41–52.
Stafen W, Trinka E, Iglseder B, Pilz P, Homann N, Ladurner G . Clinical and diagnostic findings in a patient with Creutzfeldt-Jakob disease (type Heidenhain). J Neuroimaging 1997;7:50–4.
Graham GD, Petroff OAC, Blamire AM, Rajkowska G, Goldman-Rakic P, Prichard JW . Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob disease. Neurology 1993;43:2065–8.
Shih WI, Markesbery WR, Clark DB, et al. Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). J Nucl Med 1987;28:1484–7.
Cochius JI, Hyman N, Esiri MM . Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case. J Neurol Neurosurg Psychiatry 1992;55:1094–5.
Kirk A, Ang LC . Unilateral Creutzfeldt-Jakob disease presenting as rapidly progressive aphasia. Can J Neurol Sci 1994;21:350–2.
Jibiki I, Fukushima T, Kobayashi K, et al. Utility of 123I-IMP SPECT brain scans for the early detection of site-specific abnormalities in Creutzfeldt-Jakob disease (Heidenhain type): a case study. Neuropsychobiology 1994;29:117–9.
Zeidler M, Will RG, Ironside JW, Sellar R, Wardlaw J . Magnetic resonance imaging is not a sensitive test for Creutzfeldt-Jakob disease. BMJ 1996;312:844.
Defebvre L, Destée A, Caron J, Ruchoux MM, Wurtz A, Remy J. Creutzfeldt-Jakob disease after an embolization of intercostal arteries with cadaveric dura mater suggesting a systemic transmission of the prion agent. Neurology 1997;48:1470–1.
Schwaninger M, Winter R, Hacke W, et al. Magnetic resonance imaging in Creutzfeldt-Jakob disease: evidence of focal involvement of the cortex. J Neurol Neurosurg Psychiatry 1997;63:408–9.
Bahn MM, Kido DK, Lin W, Pearlman AL . Brain magnetic resonance diffusion abnormalities in Creutzfeldt-Jakob disease. Arch Neurol 1997;54:1411–5.
Demaerel P, Baert AL, Vanopdenbosch L, Robberecht W, Dom R . Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease. Lancet 1997;349:847–8.
Bahn MM, Parchi P . Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol 1999;56:577–83.
Yee AS, Simon JH, Anderson CA, Sze C-I, Filley CM . Diffusion-weighted MRI of right-hemisphere dysfunction in Creutzfeldt-Jakob disease. Neurology 1999;52:1514.
Cohen D, Krausz Y, Lossos A, Ben-David E, Atlan H . Brain SPECT imaging with Tc-99m-PAO in Creutzfeldt-Jakob disease. Clin Nucl Med 1989;14:808–10.
Marcus HS, Duchen LW, Parkin EM, et al. Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study. Q J Med 1992;82:43–51.
Heye N, Farahati J, Heinz A, Buttner T, Przuntek H, Reiners C . Topodiagnostik der Creutzfeldt-Jakobschen Krankheit durch HMPAO-SPECT. Nukl Med 1993;32:57–9.
Victoroff J, Ross GW, Benson DF, Verity MA, Vinters HV . Posterior cortical atrophy: neuropathologic correlations. Arch Neurol 1994;51:269–74.
Aharon-Peretz J, Peretz A, Hemli JA, Honigman S, Israel O . SPECT diagnosis of Creutzfeldt-Jakob disease. J Nucl Med 1995;36:616–7.
Grunwald F, Pohl C, Bender H, et al. 18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease. Ann Nucl Med 1996;10:131–4.
Miller DA, Vitti RA, Maslack MM . The role of 99mTc-HMPAO SPECT in the diagnosis of Creutzfeldt-Jakob disease. Am J Neuroradiol 1998;19:454–5.
de Silva R, Patterson J, Hadley D, Russell A, Turner M, Zeidler M . Single photon emission computed tomography in the identification of new variant Creutzfeldt-Jakob disease: case reports. BMJ 1998;316:593–4.
Gorman DG, Benson DF, Vogel DG, Vinters HV . Creutzfeldt-Jakob disease in a pathologist. Neurology 1992;42:463.
Goldman S, Liard A, Flament-Durand J, et al. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease. Neurology 1993;43:1828–30.
Goto I, Taniwaki T, Hosokawa S, Otsuka M, Ichiya T, Ichimiya A . Positron emission tomographic (PET) studies in dementia. J Neurol Sci 1993;114:1–6.
Perani D, Cortelli P, Lucignani G, et al. [18F]FDG PET in fatal familial insomnia: the functional effects of thalamic lesions. Neurology 1993;43:2565–9.
Fisher CM . The clinical picture in Creutzfeldt-Jakob disease. Trans Am Neurol Assoc 1960;85:147–50.
Christensen E, Brun A . Subacute spongiform encephalopathy: spongiform cerebral atrophy. Neurology 1963;13:455–63.
Wakayama Y, Shibuya S, Kawase J, Sagawa F, Hashizume Y . High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease. Klin Wochenschr 1987;65:798–801.
Jimi T, Wakayama Y, Shibuya S, et al. High levels ofnervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta 1992;211:37–46.
Zerr I, Bodemer M, Racker S, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995;345:1609–10.
Zerr I, Bodemer M, Otto M, et al. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 1996;348:846–9.
Manaka H, Kato T, Kurita K, et al. Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease. Neurosci Lett 1992;139:47–9.
Awerbuch G, Peterson P, Sandyk R . Elevated cerebrospinal fluid lactic acid levels in Creutzfeldt-Jakob disease. Int J Neurosci 1988;42:1–5.
Otto M, Wiltfang J, Tumani H, et al. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 1997;225:210–2.
Otto M, Stein H, Szudra A, et al. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 1997;244:566–70.
Otto M, Wiltfang J, Kretzschmar HA, et al. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ 1998;316:577–82.
Pocchiari M . Early identification of variant Creutzfeldt-Jakob disease. BMJ 1998;316:563–4.
Heizmann CW . Subtypes of S100 proteins must be identified. BMJ 1999;318:538.
Sharief MK, Green A, Dick JPR, Gawler J, Thompson EJ . Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease. Neurology 1999;52:1289–91.
Harrington MG, Merril CR, Asher DM, Gajdusek DC . Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med 1986;315:279–83.
Zerr I, Bodemer M, Weber T . The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med 1997;336:874.
Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32–40.
Rosenmann H, Meiner Z, Kahana E, et al. Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology 1997;49:593–5.
Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG . The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924–30.
Brecher K, Stopa EG, Kenney K . Concurrent herpes simplex virus encephalitis and Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1998;64:418–9.
Moussavian M, Potolicchio S, Jones R . The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med 1997;336:873–4.
Morrison D . 14-3-3: modulators or signalling proteins? Science 1994;266:56–7.
Roos R, Gajdusek DC, Gibbs CJ . Liver disease in Creutzfeldt-Jakob disease (subacute spongiform encephalopathy). Neurology 1971;21:397–8.
Tanaka M, Iizuka O, Tatsuhiko Y . Hepatic dysfunction in Creutzfeldt-Jakob disease. Neurology 1992;42:1249.
Tanaka M, Tanaka K, Miyatake T . Lymphocytes in Creutzfeldt-Jakob disease. Neurology 1993;43:2155–6.
Iwasaki Y, Kinoshita M . Liver in Creutzfeldt-Jakob disease. Neurology 1993;43:457.
Leblhuber F, Walli I, Tilz GP, Jellinger K, Wachter H, Fuchs D . Increased serum neopterin concentrations in a patient with Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1996;61:211–2.
Meiner Z, Halimi M, Polakiewicz RD, Prusiner SB, Gabizon R . Presence of prion protein in peripheral tissues of Libyan Jews with Creutzfeldt-Jakob disease. Neurology 1992;42:1355–60.
Schreuder BE, van Keulen LI, Vromans ME, Langeveld JP, Smits MA . Tonsillar biopsy and PrPSc detection in the preclinical diagnosis of scrapie. Vet Rec 1998;142:564–8.
Hill AF, Zeidler M, Ironside I, Collinge J . Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349:99–100.
Kawashima T, Furukawa H, Doh-ura K, Iwaki T . Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;350:68–9.
Collinge I, Rossor MN, Thomas D, Frosh A, Tolley N . Tonsil biopsy helps diagnose new variant Creutzfeldt-Jakob disease. BMJ 1998;317:472.
Zeidler M, Knight R, Stewart G, et al. Routine tonsil biopsy for diagnosis of new variant Creutzfeldt-Jakob disease is not justified. BMJ 1999;318:538.
O'Rourke KL, Baszler TV, Parish SM, Knowles DP . Preclinical detection of PrPSc in nictitating membrane lymphoid tissue of sheep. Vet Rec 1996;142:489–91.
Hilton DA, Fathers E, Edwards P, Ironside JW, Zaijcek J . Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998;352:703–4.
Bernoulli C, Siegfried I, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977;1:478–9.
Gibbs CJ, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC . Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry 1994;57:757–8.
Foncin JF, Gaches J, Cathala F, El Sherif E, Le Beau J . Transmission iatrogene interhumaine possible de maladie de Creutzfeldt-Jakob avec atteinte des grains du cervelet. Rev Neurol (Paris) 1980;136:280.
Will RG, Matthews WB . Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982;45:235–8.
Nevin S, McMenemey WH, Behrman S, Jones DP . Subacute spongiform encephalopathy: a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain 1960;83:519–64.
Gaches J, Supino-Viterbo V, Oughourlian JM . Unusual electroencephalographic and clinical evolution of a case of meningioma of the left temporo-occipital convexity. Eur Neurol 1971;5:155–64.
Prichard I, Thadani V, Kalb R, Manuelidis E, Hadler J . Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR 1987;36:49–55.
Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft: case report. J Neurosurg 1988;69:766–9.
Masullo C, Pocchiari M, Macchi G, Alema G, Piazza G, Panzera MA . Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg 1989;71:954–5.
Nisbet TJ, Donaldson IM, Bishara SN . Update: Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. MMWR 1989;38:37–43.
Nisbet TJ, MacDonaldson I, Bishara SN . Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. JAMA 1989;261:1118.
Willison HI, Gale AN, McLaughlin JE . Creutzfeldt-Jakob disease following cadaveric dura mater graft. J Neurol Neurosurg Psychiatry 1991;54:940.
Martinez-Lage JF, Sola J, Poza M, Esteban JA . Pediatric Creutzfeldt-Jakob disease: probable transmission by a dural graft. Childs Nerv Syst 1993;9:239–42.
Takayama S, Hatsuda N, Matsumura K, Nakasu S, Handa J . Creutzfeldt-Jakob disease transmitted by cadaveric dural graft: a case report. No Shinkei Geka - Neurol Surg 1993;21:167–70.
Lane KL, Brown P, Howell DN, et al. Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery 1994;34:737–40.
Clavel M, Clavel P . Creutzfeldt-Jakob disease transmitted by dura mater graft. Eur Neurol 1996;36:239–40.
Takashima S, Tateishi J, Taguchi Y, et al. Creutzfeldt-Jakob disease with a widespread presence of kuru-type plaques after cadaveric dural graft replacement: an autopsy case. Rinsho Shinkeigaku - Clin Neurol 1997;37:824–8.
Radbauer C, Hainfellner JA . Gaudernak T, Deecke L, Budka H. Creutzfeldt-Jakob-Krankheit bei einem Dura-Transplantat-Empfanger: Erstbeobachtung in Osterreich. Wien Klin Wochenschr 1998;110:496–500.
Sato T, Hoshi K, Yoshino H, Urata I, Nakamura Y, Yanagawa H . Creutzfeldt-Jakob disease associated with dura mater grafts: Japan, January 1979-May 1996. JAMA 1998;279:11–2.
Diringer H, Braig HR . Infectivity of unconventional viruses in dura mater. Lancet 1989;I:439–40.
Tange RA, Troost D, Limburg M . Progressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closure. Eur Arch Oto-Rhino-Laryngol 1990;247:199–201.
Hintz R, MacGillivray M, Joy A, Tintner R . Fatal degenerative neurological disease in patients who received pituitary-derived human growth hormone. MMWR 1985;34:359–66.
Gibbs CJ, Joy A, Heffner R, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 1985;313:734–8.
Weller RO, Steart PV, Powell-Jackson JD . Pathology of Creutzfeldt-Jakob disease associated with pituitary-derived human growth hormone administration. Neuropathol Appl Neurobiol 1986;12:117–29.
Croxson M, Brown P, Synek B, et al. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand. Neurology 1988;38:1128–30.
Marzewski DI, Towfighi J, Harrington MG, Merril CR, Brown P . Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case. Neurology 1988;38:1131–3.
Buchanan CR, Preece MA, Milner RDG . Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ 1991;302:824–8.
Fradkin JE, Schonberger LB, Mills JL, et al. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA 1991;265:880–4.
Macario ME, Vaisman M, Buescu A . Moura Neto V, Auaujo HMM, Chagas C. Pituitary growth hormone and Creutzfeldt-Jakob disease. BMJ 1991;302:1149.
Billette de Villemeur T, Gourmelen M, Beauvais P, et al. Maladie de Creutzfeldt-Jakob chez quatre enfants traités par hormone de croissance. Rev Neurol (Paris) 1992;148:328–34.
Ellis CJ, Katifi H, Weller RO . A further British case of growth hormone induced Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1992;55:1200–2.
Delisle MB, Fabre N, Rochiccioli P, Doerr-Schott J, Rumeau JL, Bes A . Maladie de Creutzfeldt-Jakob après traitement par l'hormone de croissance extractive humaine: étude clinico-pathologique. Rev Neurol (Paris) 1993;149:524–7.
New MI, Brown P, Temeck JW, Owens C, Hedley-White ET, Richardson EP . Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient. Neurology 1988;38:1133–4.
Preece MA . Creutzfeldt-Jakob disease: implications for growth hormone deficient children. Neuropathol Appl Neurobiol 1986;12:509–15.
Brown P . The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy. Neurology 1988;38:1135–7.
Brown P . Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts. Pediatrics 1988;81:85–92.
Brown P . Iatrogenic Creutzfeldt-Jakob disease. Aust NZ J Med 1990;20:633–5.
Job JC, Maillard F, Goujard J . Epidemiologic survey of patients treated with growth hormone in France in the period 1959-1990. Horm Res 1992;38(Suppl 1):35–43.
Brown P, Gajdusek DC, Gibbs CJ, Asher DM . Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 1985;313:728–31.
Perry HM . Risk of Creutzfeldt-Jakob disease in bodybuilders. BMJ 1993;307:803.
Verdrager J . New variant Creutzfeldt-Jakob disease and bovine pituitary growth hormone. Lancet 1998;351:112–3.
Brown P . Environmental causes of human spongiform encephalopathy. In: Baker HF, Ridley RM, editors. Methods in molecular medicine: prion diseases. Totowa, NJ: Humana Press, 1996:139–54.
Manuelidis EE, Kim JH, Mericangas JR, Manuelidis L . Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancet 1985;11:896–7.
Tarnai Y, Kojima H, Kitajima R, et al. Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease. N Engl J Med 1992;327:649.
Manuelidis EE, Gorgacz EJ, Manuelidis L . Viremia in experimental Creutzfeldt-Jakob disease. Science 1978;200:1069–71.
Diringer H . Sustained viremia in experimental hamster scrapie. Arch Virol 1984;82;105–9.
Brown P . Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr Opin Hematol 1995;2:472–7.
Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN . The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998;38:810–6.
Ludlam CA . New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Lancet 1997;350:1704.
Little BW, Mastranni J, DeHaven AL, Brown P, Goldfarb L, Gajdusek DC . The epidemiology of Creutzfeldt-Jakob disease in Eastern Pennsylvania. Neurology 1993;43:A316.
Esmonde TFG, Will RG, Slattery JM, et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993;341:205–7.
Kondo K, Kuroiwa Y . A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 1982;11:377–81.
Wientjens DPWM, Davanipour Z, Hofman A . et al . Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology 1996;46:1287–91.
Van Duijn CM, Delasnerie-Lauprêtre N, Masullo C, et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. Lancet 1998;351:1081–5.
Ricketts MN, Cashman NR, Stratton EE, El Saadany S. Is Creutzfeldt-Jakob disease transmitted in blood? Emerg Infect Dis 1997;3:155–63.
Watkins AM . Creutzfeldt-Jakob disease and blood transfusion. BMJ 1991;302:1537.
Klein R, Dumble LJ . Transmission of Creutzfeldt-Jakob disease by blood transfusion. Lancet 1993;341:708.
Heye N, Hensen S, Muller N . Creutzfeldt-Jakob disease and blood transfusion. Lancet 1994;343:298–9.
Creange A, Gray F, Cesaro P, et al. Creutzfeldt-Jakob disease after liver transplantation. Ann Neurol 1995;38:269–72.
Riggs JE . Creutzfeldt-Jakob disease in a prolific blood donor. Arch Neurol 1997;54:1323.
Patry D, Curry B, Easton D, Mastrianni JA, Hogan DB . Creutzfeldt-Jakob disease (CJD) after blood product transfusion from a donor with CJD. Neurology 1998;50:1872–3.
Collins S, Masters CL . Iatrogenic and zoonotic Creutzfeldt-Jakob disease: the Australian perspective. Med J Austral 1996;164:598–602.
Herzberg L . Creutzfeldt-Jakob disease and corneal grafts. Med J Austral 1979;1:248.
World Health Organization. Report of WHO consultation on medicinal and other products in relation to human and animal transmissible spongiform encephalopathies. Geneva: World Health Organization, 1999.
Contreras M, Barbara J . Creutzfeldt-Jakob disease and blood transfusion. BMJ 1991;302:1148–9.
Herzberg L, Herzberg BN, Gibbs CJ, Sullivan W, Amyx H, Gajdusek DC . Creutzfeldt-Jakob disease: hypothesis for high incidence in Libyan Jews in Israel. Science 1974;186:848.
Alter M . Creutzfeldt-Jakob disease: hypothesis for high incidence in Libyan Jews in Israel. Science 1974;186:848.
Alter M, Frank Y, Doyne H, Webster DD . Creutzfeldt-Jakob disease after eating ovine brains? N Engl J Med 1975;292:927.
Alter M, Kahana E . Creutzfeldt-Jakob disease among Libyan Jews in Israel. Science 1976;192:428.
Alter M, Hoenig E, Pratzon G . Creutzfeldt-Jakob disease: possible association with eating brains. N Engl J Med 1977;296:820–1.
Mitrova E, Mayer V . Inherited susceptibility, ovine brain consumption and Creutzfeldt-Jakob disease (CJD). J Neurol 1981;226:219–20.
Kamin M, Patten BM . Creutzfeldt-Jakob disease: possible transmission to humans by consumption of wild animal brains. Am J Med 1984;76:142–5.
Berger JR, Waisman E, Weisman B . Creutzfeldt-Jakob disease and eating squirrel brains. Lancet 1997;350:642.
Davanipour Z, Alter M, Sobel E, Asher DM, Gajdusek DC . A case-control study of Creutzfeldt-Jakob disease: dietary risk factors. Am J Epidemiol 1985;122:443–51.
Hansen M . Creutzfeldt-Jakob disease. N Engl J Med 1999;340:1687–8.
Aguzzi A . Neuro-immune connection in spread of prions in the body? Lancet 1997;349:742–3.
Collinge J, Hawke S . B lymphocytes in prion neuroinvasion: central or peripheral players? Nature Med 1998;4:1369–70.
Alpers M . Epidemiology and clinical aspects of kuru. In: Prusiner SB, McKinley SB, editors. Prions: novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. San Diego: Academic Press, 1987:451–65.
Brown P, Cervenakova L, McShane L, et al. Creutzfeldt-Jakob disease in a husband and wife. Neurology 1998;50:684–8.
Zanusso G, Nardelli E, Rosati A, et al. Simultaneous occurrence of spongiform encephalopathy in a man and his cat in Italy. Lancet 1998;352:1116–7.
Scott JR, Foster JD, Fraser H . Conjunctival instillation of scrapie in mice can produce disease. Vet Microbiol 1993;34:305–9.
Fraser JR, Foster JD, Fraser H . Scrapie can be transmitted to mice by instillation of inoculum into the conjunctiva. BMJ 1996;312:181.
Marsh RF, Hanson RP . Transmissible mink encephalopathy: infectivity of corneal epithelium. Science 1975;187:656.
Manuelidis EE, Angelo IN, Gorgacz EJ, Kim JH, Manuelidis L . Experimental Creutzfeldt-Jakob disease transmitted via the eye with infected cornea. N Engl J Med 1977;296:1334–6.
Hogan RN, Bowman KA, Baringer JR, Prusiner SB . Replication of scrapie prions in hamster eyes precedes retinal degeneration. Ophthalmic Res 1986;18:230–5.
Tateishi J . Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice. Lancet 1985;II:1074.
Fraser H, Dickinson AG . Targeting of scrapie lesions and spread of agent via the retino-tectal projection. Brain Res 1985;346:32–41.
Liberski PP, Yanagihara R, Gibbs CJ, Gajdusek DC . Spread of Creutzfeldt-Jakob disease virus along visual pathways after intraocular inoculation. Arch Virol 1990;111:141–7.
Scott JR, Fraser H . Enucleation after intraocular scrapie injection delays the spread of infection. Brain Res 1989;504:301–5.
Uchiyama S, Ishida C, Yago S, Kurumaya H, Kitamoto T . An autopsy case of Creutzfeldt-Jakob disease associated with corneal transplantation. Dementia 1994;8:466–73.
DeVoe AG . Complications of keratoplasty. Am J Ophthalmol 1975;79:907–12.
Allan B, Tuft S . Transmission of Creutzfeldt-Jakob disease in corneal grafts. BMJ 1997;315:1553–4.
Henderson M . Health alert after the eyes of CJD victim are transplanted. The London Times, 1 December 1997, London.
Christie B . Inquiry ordered after organ donor found to have CJD. BMJ 1997;315:1485.
Stewart W . Independent review of an eye transplantation/CJD incident in 1997 London: Royal College of Ophthalmologists, 1998.
Morrice GD . CJD was not diagnosed until eight months after organ donor's death. BMJ 1998;316:630.
Tullo A . CJD and the eye. Focus 1998;7:1–2.
O'Day DM . Diseases potentially transmitted through corneal transplantation. Ophthalmology 1989;96:1133–8.
Hogan RN, Cavanagh HD . Transplantation of corneal tissue from donors with diseases of the central nervous system. Cornea 1995;14:547–53.
Davanipour Z, Goodman L, Alter M, Sobel E, Asher D, Gajdusek DC Possible modes of transmission of Creutzfeldt-Jakob disease. N Engl J Med 1984;311:1582–3.
Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek DC Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 1985;35:1483–6.
Fross RD . Ophthalmological precautions in Creutzfeldt-Jakob disease. Ann Neurol 1986;20:748.
Davanipour Z, Ziogas A, Sobel E, et al. Ocular tonometry and transmissible spongiform encephalopathy. Am J Epidemiol 1998;147 (Suppl):S76.
Rizzo M, Corbett JJ, Thompson HS . Is applanation tonometry a risk factor for transmission of Creutzfeldt-Jakob disease? Arch Ophthalmol 1987;105:314.
Schoene WC, Masters CL, Gibbs CJ, et al. Transmissible spongiform encephalopathy (Creutzfeldt-Jakob disease): atypical clinical and pathological findings. Arch Neurol 1981;38:473–7.
Miller DC . Creutzfeldt-Jakob disease in histopathology technicians. N Engl J Med 1988;318:853–4.
Sitwell L, Lach B, Atack E, Atack D, Izukawa D . Creutzfeldt-Jakob disease in histopathology technicians. N Engl J Med 1988;318:854.
Berger JR, David NJ . Creutzfeldt-Jakob disease in a physician: a review of the disorder in health care workers. Neurology 1993;43:205–6.
Berger JR, David NJ . CJD in health care workers. Neurology 1993;43:2421.
Weber T, Tumani H, Holdorff B, et al. Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet 1993;341:123–4.
Traub RD, Gadjusek DC, Gibbs CJ . Precautions in conducting biopsies and autopsies on patients with presenile dementia. J Neurosurg 1974;41:394–5.
Traub RD, Gajdusek DC, Gibbs CJ . Precautions in autopsies on Creutzfeldt-Jakob disease. Am J Clin Pathol 1975;64:287.
Gajdusek DC, Gibbs CJ, Asher DM, et al. Precautions in medical care of, and in handling materials from patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med 1977;297:1253–8.
Budka H, Aguzzi A . Brown P, et al. Konsensusbericht: Gewebsbehandlung bei Verdacht auf Creutzfeldt-Jakob-Krankheit und andere spongiforme Enzephalopathien (Prionen-Krankheiten) des Menschen. Pathologe 1996;17:171–6.
Advisory Committee on Dangerous Pathogens Spongiform Encephalopathy Advisory Committee. Transmissible spongiform encephalopathy agents: safe working and the prevention of infection. London: HMSO, 1998.
Hernà ndez-Palazôn J, Martinez-Lage JF, Tortosa JA . Garcia-Cayuela JM . Anaesthetic management in patients suspected of, or at risk of, having Creutzfeldt-Jakob disease. Br J Anaesth 1998;80:516–8.
Aguzzi A, Collinge J . Post-exposure prophylaxis after accidental prion inoculation. Lancet 1997;350:1519–20.
Dealler S . Post-exposure prophylaxis after accidental prion inoculation. Lancet 1998;351:600.
Brown P, Rohwer RG, Gajdusek DC Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus. N Engl J Med 1984;310:727.
Committee on Health Care Issues ANARRN, White CL, Brown P, et al. Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Ann Neurol 1986;19:75–7.
Rappaport EB . Iatrogenic Creutzfeldt-Jakob disease. Neurology 1987;37:1520–2.
Wight A . PL(92)CO/4: Neuro and ophthalmic surgery procedures on patients with or suspected to have, or at risk of developing, Creutzfeldt-Jakob disease (CJD), or Gerstmann-Straussler-Scheinker syndrome (GSS). J Public Health Med 1993;15:209–10.
Metters JS . Neuro and ophthalmic surgery procedures on patients with or suspected to have, or at risk of developing, Creutzfeldt-Jakob disease (CJD), or Gerstmann-Straussler-Scheinker syndrome (GSS). J Public Health Med 1993;15:210–1.
Holmes SJ, Ironside JW, Shalet SM . Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood. J Neurol Neurosurg Pyschiatry 1996;60:333–5.
Dormont D . Creutzfeldt-Jakob disease and transplantation: facts and fables. Transplant Proc 1996;28:2931–3.
Eye Bank Association of America. Medical Standards. 8–12. 1994.
Austin JH . Precautions in Creutzfeldt-Jakob disease. Ann Neurol 1986;20:748.
Zeidler M, Brown P . More patients should be excluded from being tissue donors. BMJ 1998;316:1170–1.
SEAC Summary of spongiform encephalopathy advisory committee meeting on 3 June, 1999. SEAC 1/99. 23 June 1999.
Brown P, Gibbs CJ, Amyx HL, et al. Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med 1982;306:1279–82.
Ernst DR, Race RE . Comparative analysis of scrapie agent inactivation methods. J Virol Methods 1993;41:193–201.
Taylor DM, McConnell I . Autoclaving does not decontaminate formol-fixed scrapie tissues. Lancet 1988;1:1463–4.
Brown P, Wolff A, Gajdusek DC . A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990;40:887–90.
Manuelidis L . Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. J Neurovirol 1997;3:62–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lueck, C., McIlwaine, G. & Zeidler, M. Creutzfeldt-Jakob disease and the eye. I. Background and patient management. Eye 14, 263–290 (2000). https://doi.org/10.1038/eye.2000.75
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/eye.2000.75
This article is cited by
-
Creutzfeldt-Jakob-Krankheit: Erfahrungen der Augenabteilung des Hanuschkrankenhauses der Wiener Gebietskrankenkasse (WGKK)
Spektrum der Augenheilkunde (2006)
-
Comparison between standard Goldmann applanation prism and disposable applanation prism in tonometry
Eye (2004)
-
Debris on processed ophthalmic instruments: a cause for concern
Eye (2003)
-
Debris on processed ophthalmic instruments: a cause for concern
Eye (2002)
-
Evaluation of a disposable prism for applanation tonometry
Eye (2001)